Buyback Spend for ResMed (RMD)
Buyback Spend for ResMed (RMD): headline value $500.06M · YoY +100.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingBuyback SpendSwitch metric
Latest period
$500.06M
YoY change
+100.0%
5Y CAGR
N/A
Peak year (2012)
$392.74M
Latest annual
$300.02M
Buyback Spend history chart for ResMed (RMD) from 1993 to 2025
Buyback Spend history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $300.02M | +100.0% | ||
| 2024 | $150.01M | — | ||
| 2023 | $0 | — | ||
| 2022 | $0 | — | ||
| 2021 | $0 | — | ||
| 2020 | $0 | -100.0% | ||
| 2019 | $22.84M | -57.5% | ||
| 2018 | $53.80M | — | ||
| 2017 | $0 | -100.0% | ||
| 2016 | $102.06M | -36.3% | ||
| 2015 | $160.30M | -20.7% | ||
| 2014 | $202.17M | +8.5% | ||
| 2013 | $186.26M | -52.6% | ||
| 2012 | $392.74M | +140.4% | ||
| 2011 | $163.34M | +24.6% | ||
| 2010 | $131.08M | +91.1% | ||
| 2009 | $68.59M | -29.0% | ||
| 2008 | $96.56M | +4515.5% | ||
| 2007 | $2.09M | — | ||
| 2006 | $0 | -100.0% | ||
| 2005 | $10.97M | -42.4% | ||
| 2004 | $19.03M | +437.2% | ||
| 2003 | $3.54M | -55.0% | ||
| 2002 | $7.87M | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | -100.0% | ||
| 1994 | $300,000 | — | ||
| 1993 | $0 | — |
Buyback Spend values are taken from ResMed's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual buyback spend for ResMed (RMD) came in at $300.02M – surged 100.0% year-over-year.
Across 2015–2025 (10 years), ResMed buyback spend produced a CAGR of +6.5% – sustaining 2 straight years of year-over-year growth.
ResMed buyback spend declined from $392.74M in 2012 to $300.02M in 2025, a 23.6% drawdown.
The highest annual buyback spend of $392.74M was reported in 2012. The lowest in the available history was $0 in 1993.
Among 8 Healthcare peers, ResMed (RMD) ranks 8th; the peer median for buyback spend is $2.75B.
ResMed Buyback Spend by Year
ResMed Buyback Spend 2025: $300.02M
ResMed buyback spend in 2025 was $300.02M, surged 100.0% from 2024.
ResMed Buyback Spend 2024: $150.01M
ResMed buyback spend in 2024 was $150.01M.
ResMed Buyback Spend 2023: $0
ResMed buyback spend in 2023 was $0.
ResMed Buyback Spend 2022: $0
ResMed buyback spend in 2022 was $0.
ResMed Buyback Spend 2021: $0
ResMed buyback spend in 2021 was $0.
See more financial history for ResMed (RMD).
Sector peers — Buyback Spend
Companies in the same sector as ResMed, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is ResMed's buyback spend?
Latest reported buyback spend for ResMed (RMD) is $500.06M (period ending December 31, 2025).
How has ResMed buyback spend changed year-over-year?
ResMed (RMD) buyback spend changed +100.0% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed buyback spend?
ResMed (RMD) buyback spend compound annual growth rate is +6.5% over the most recent 10 years available.
When did ResMed buyback spend hit its highest annual value?
ResMed buyback spend reached its highest annual value of $392.74M in 2012.
What was ResMed buyback spend in 2024?
ResMed (RMD) buyback spend in 2024 was $150.01M.
What was ResMed buyback spend in 2025?
ResMed (RMD) buyback spend in 2025 was $300.02M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.